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Background: Since drug-related emergency department (ED) visits are common among older adults, the objectives
of our study were to identify the frequency of drug-related problems (DRPs) among patients presenting to the ED
with non-specific complaints (NSC), such as generalized weakness and to evaluate responsible drug classes.
Methods: Delayed type cross-sectional diagnostic study with a prospective 30 day follow-up in the ED of the
University Hospital Basel, Switzerland. From May 2007 until April 2009, all non-trauma patients presenting to the ED
with an Emergency Severity Index (ESI) of 2 or 3 were screened and included, if they presented with non-specific
complaints. After having obtained complete 30-day follow-up, two outcome assessors reviewed all available
information, judged whether the initial presentation was a DRP and compared their judgment with the initial ED
diagnosis. Acute morbidity (“serious condition”) was allocated to individual cases according to predefined criteria.
Results: The study population consisted of 633 patients with NSC. Median age was 81 years (IQR 72/87), and the
mean Charlson comorbidity index was 2.5 (IQR 1/4). DRPs were identified in 77 of the 633 cases (12.2%). At the
initial assessment, only 40% of the DRPs were correctly identified. 64 of the 77 identified DRPs (83%) fulfilled the
criteria “serious condition”. Polypharmacy and certain drug classes (thiazides, antidepressants, benzodiazepines,
anticonvulsants) were associated with DRPs.
Conclusion: Elderly patients with non-specific complaints need to be screened systematically for drug-related
problems.
Trial registration: ClinicalTrials.gov:NCT00920491Background
Drug-related ED visits are common. Up to 25% of ED
consultations by elderly patients are due to drug-related
problems (DRPs), depending on the definitions of DRP
used [1-6]. Older patients are more frequently affected
by DRPs than younger ones [1,2,7]. Contributing factors
are physiologic changes associated with aging, which
include impaired renal and hepatic function, as well as
decreased total body water and lean body mass [8]. Ad-
ditionally, older adults use more medications because of
the co-existence of multiple comorbidities [9,10]. As a* Correspondence: nickelc@uhbs.ch
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reproduction in any medium, provided the orconsequence, polypharmacy is highly prevalent in the
older patient [11]. Furthermore, the presence of demen-
tia or confusion may lead to patient errors due to com-
plex medication regimens, resulting in DRPs [12,13].
Emergency Physician recognition of DRPs appears to
be dependent on the mode of presentation [14]. Patients
with DRPs can present to the ED with specific symp-
toms, e.g. rash, bleeding, arrhythmias, or hypoglycemia
[15,16]. However, patients with DRPs may also present
with non-specific complaints (NSC), such as generalized
weakness which may make a DRP more difficult to be
identified, considering the fact that ED physicians are
failing to identify DRPs in up to 40% even in a general
ED population [3].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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on falls and delirium [17,18], but up to 20% of elderly
patients present to the ED with NSC, and the underlying
cause of their symptoms is often not known [19,20]. Im-
portantly, patients with NSC are at risk of adverse health
outcomes [21-23]; probably because of their often older
age, cognitive and functional impairment, multiple co-
morbidities, and sub-acute or atypical presentation of
acute illness [19,24,25]. This patient group with NSC po-
ses significant challenges to emergency physicians (EPs),
as the differential diagnostic spectrum is so wide, ranging
from lack of social support to life-threatening disease
[26,27]. The need for research and training in this area has
been addressed [28,29].
Currently it is not known how many patients with
NSC suffer from DRPs. DRPs represent an important,
potentially preventable and curable condition [30]. It can
be speculated that DRPs in patients with NSC may be
overlooked. Therefore, the objectives of our study were
to identify the frequency of DRPs among patients pre-
senting to the ED with NSC, to evaluate drugs and clas-
ses being associated with such DRPs and to assess the
proportion of missed DRPs in the initial assessment. An
additional aim was to determine the frequency of DRPs
associated with acute morbidity.
Methods
Study design
This present study is a predefined part of the prospective
Basel-non-specific complaints (BANC) study [22] with
diagnostic assessment after a 30 day follow-up period by
a panel of experts, representing a delayed type cross-
sectional study [31]. The study protocol was approved
by the local ethics committee (www.ekbb.ch, Reference
Number EKBB 73/07) and it is registered with Clinical
Trials (www.clinicaltrials.gov, NCT00920491). It is in
compliance with the Helsinki Declaration.
Study setting and population
The study was carried out in the ED of the University
Hospital Basel, Switzerland. The hospital is an urban
700-bed tertiary care center with an ED census of over
41’000 patients per year. From May 24th 2007 until
April 15th 2009, all non-trauma patients 18 years of age
or older with an Emergency Severity Index (ESI) level of
2 or 3 [32] presenting to the ED were consecutively
screened for inclusion. The ESI, a 5-level triage tool with
proven reliability and validity for the German translation
[33] was used in order to exclude all patients with life-
threatening conditions (ESI 1), as well as patients with
conditions in which a full work-up was not intended
(“see-and-treat” pathway, ESI 4 and 5). All ED patients
were screened twice for inclusion: First by a triage-nurse
in order to include all ESI 2 and ESI 3 patients andsecondly each resident on duty screened all ESI 2 and
ESI 3 patients for their presenting symptoms using a
one-page screening tool. Enrolment was then carried out
by 3 previously trained study physicians.
Inclusion criteria
Patients were included if they presented with NSC.
NSCs are defined as the entity of complaints which are
not part of the set of specific complaints or signs or
where an initial working diagnosis cannot be definitively
established [22]. For such complaints, no evidence-based
management protocols (EPs) exist. Typical examples of
NSC are “generalized weakness”, “general deterioration”
or “lack of community support” [34,35].
Exclusion criteria
Patients with specific complaints (e.g. syncope, chest pain)
were not included. Hemodynamically unstable patients or
with vital parameters significantly out of the normal range
(systolic blood pressure <80 or >180 mmHg, respira-
tion rate >20/min, tympanal body temperature >38.5°C,
SpO2 < 92%) were also excluded. Patients with abnormal
vital signs can be considered as “specific”, since work-up
is generally straight-forward, for example for shock, even
when the symptoms are non-specific. In addition, patients
with known terminal conditions as well as patients refer-
red from other hospitals were not eligible for inclusion.
Measurements
Demographic baseline data, ESI, all complaints (using a
structured interview form), vital signs (pulse, blood pres-
sure, respiratory rate, and oxygen saturation), Glasgow
Coma Scale, medical history, physical examination, and
electrocardiography reading were obtained on arrival
and registered on the patient’s case report form. Add-
itionally, the body mass index (BMI) was calculated. For
quantification of comorbidities the Charlson Comorbid-
ity Index was used [36]. This tool has been validated for
population-based studies to estimate the risk of death.
Lab testing was done in all patients and, in the vast ma-
jority, chest X-ray and urinalysis was performed. Treat-
ment was initiated at the discretion of the ED physician
in charge.
Assessment of medication
We assessed all drugs reported by the patient during
a bedside interview, or reported by proxies or by the
family physician, or found in our electronic patient re-
cords. Drugs were grouped into predefined pharma-
cological classes (Table 1). Additionally, we analyzed the
drugs recorded according to the Beers criteria, a list of
potentially inappropriate medications in older adults
which aims to minimize drug-related problems [37]. The
Beers criteria are regularly updated [38] and based on




(total n = 633)
Diuretics (all types) 294 46.4
Non-thiazide diuretics 225 41.4
Thiazide diuretics 136 21.5
ACE inhibitors/AR blockers 231 36.5
Beta-blockers 211 33.3
Other cardiovascular drugs† 129 20.4
Platelet aggregation inhibitors 236 37.3
Vitamin K- antagonists 90 14.2
Systemic steroids 47 7.4
NSAID 98 15.5
Opioids 69 10.9






Anti-Parkinson drugs 48 7.6
†calcium channel blockers, nitrates, digoxine, amiodarone.
‡other hypnotica such as barbiturates, zopiclone and zolpidem and others,
such as St. Johns Worth.
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review and a questionnaire. They have been evaluated by
recognized experts in geriatric care, clinical pharmacol-
ogy and psychopharmacology.Patient follow up and endpoint ascertainment
Written 30-day follow-up data was obtained from hos-
pital discharge reports or the patients’ primary care phy-
sicians (questionnaire). Outcome assessors reviewed all
available medical records and data of the study patients
from the time of ED presentation to 30-day follow-up.
Six ED physicians one of whom is a clinical pharmacolo-
gist, all certified in internal medicine and experienced in
emergency medicine (outcome assessors) were available
for outcome ascertainment. In each session, two out-
come assessors, reviewed all discharge records and es-
tablished a final “gold standard” diagnosis according to
the 10th International Classification of Diseases and
Related Health Problems (ICD-10). Furthermore, the
diagnoses were evaluated to be drug-related or not using
Micromedex [39]. For each medication entered, a detailed
list of possible DRPs was produced using Micromedex.
Where needed, a board-certified clinical pharmacologist
was consulted. In the 22 cases of disagreement between
outcome assessors, cases were reviewed and adjudicatedin conjunction with the BANC expert panel, consisting of
two physicians certified in internal medicine with at least
10 years of clinical experience as previously described [22].
In a second step, the expert panel classified the DRP
according to the Pharmaceutical Care Network Europe
(PCNE) Classification (see below) [40].
The DRPs identified as described above were compared
with the ED diagnoses given on the day of the visit. By
comparison, the proportion of missed DRPs could be
identified.
Definition and classification of drug-related problems
(DRPs)
According to the PCNE Classification V 5.01, DRPs are
defined as “events or circumstances involving drug ther-
apy actually or potentially interfering with desired health
outcomes” [40]. In this classification, DRPs can be
assigned to six main categories, so-called “primary do-
mains” P1-P6: (P1) adverse drug reaction (allergic, non-
allergic or toxic side-effects), (P2) drug choice problem
(patient gets or is going to get a wrong (or no drug) drug
for his/her disease and/or condition), (P3) dosing prob-
lem (patient gets more or less than the amount of drug
he/she requires), (P4) drug use problem (wrong or no
drug taken/administered), (P5) drug-drug interactions,
and (P6) others. We chose the PCNE classification, since
it has been shown to contain all required aspects to de-
scribe and classify DRPs for research and practice pur-
pose [41]. Furthermore, it has been evaluated in our
institution and is considered to be a practical tool in the
hospital setting [42]. Polypharmacy was defined as the
prescription of 6 or more drugs at presentation [43].
Serious condition
A “serious condition” was attributed to individual cases
using predefined criteria that are covered in a compre-
hensive list [22]. Briefly, a “serious condition” was de-
fined as a potentially life-threatening condition, or any
condition requiring an early intervention (e.g. central
nervous dysfunction due to hyponatremia) to prevent
health status deterioration leading to potential morbidity
or death within 30 days of the initial ED presentation.
Data analysis
In case of categorical variables, crosstables were calcu-
lated. In case of ordinal or metric variables, mean, me-
dian, standard deviation, minimum, maximum were
calculated. To predict the influence of the number of
concomitantly prescribed drugs and of certain drug clas-
ses (e.g. diuretics, psychotropic drugs) on the outcomes
DRP or DRP with “serious condition”, a logistic regression
model was chosen. Adjustment for age, gender and co-
morbidities was performed by adding these cofactors to
the regression model. Results are presented as two-sided
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95% confidence intervals. In the case of continuous or or-
dinal predictors, the OR is expressed as the ratio of the
odds increasing the predictor from the 1rd to the 3st quar-
tile (25 and 75 percentile, respectively), representing a
typical above average to a typical below average value. A
p-value < 0.05 was considered significant. This study is ex-
ploratory; therefore p-values were not adjusted for mul-
tiple comparisons. All analyses were done using R v 2.8.0
(A Language and Environment for Statistical Computing).
Results
From May 24th 2007 until April 15th 2009, 22’782 non-
trauma patients presented to the ED. 9926 patients were
triaged as ESI level 2 or ESI 3 and therefore screened for
inclusion into the current study. Of these, 714 patients
(7.2%) presented with NSC and were consecutively en-
rolled in our study (see Figure 1). During post-hoc case
reviews, the BANC expert panel recalled the inclusion of
81 patients due to the presence of exclusion criteria,
mostly due to the presence of specific complaints. The
final study population consisted of 633 patients with NSC.
No patient was lost to follow-up. Baseline characteristics
of the study population are presented in Table 2. Median22’782 non-trauma p
24th 2007 until Ap
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77 Patients with a DRP (12.2%)
Figure 1 Study outline.age was 81 years (IQR 72/87), 62.6% of subjects were fe-
male, median BMI was 23.4 kg/m2 (IQR 20.4/26.4). Mean
Charlson comorbidity index was 2.5 (IQR 1/4). 581 pa-
tients (91.7%) took 1 or more medications (prescribed, or
over the counter). The number of medications taken
ranged from 0 to 17 with a median number of 5 drugs
(IQR 3/8). The detailed analyses of the drug categories are
presented in Table 1.
A total number of 77 patients with DRPs were identi-
fied, attributing to 12.2% of the total study population
(633 patients). A “Serious Condition” as defined above
was detected in 64 of the 77 identified DRPs (83%). Of
the 633 patients with NSC screened for DRPs, 387 suf-
fered from a “serious condition” (61%). The comparison
of the 77 cases with a DRP with the initial ED diagnosis
given on the day of the visit revealed that 48 cases
with a DRP (60%) were initially not identified. Most com-
monly missed drug-related diagnoses were electrolyte dis-
orders (hyponatremia and others, 20 cases), hypovolemia
(7 cases) and intoxications (5 cases).
42 DRPs (56% of all DRPs) were classified under the
P1 domain “adverse drug reactions (ADR)”. Nine DRPs
(12% were classified as P2 (drug choice problem), 16
(21%) as P3 (dosing problems), 2 (3%) as P4 (drug useatients from May 
ril 15th 2009  
9212 patients excluded with specific 
complaints
ESI 2 or 3 eligible 
sion
Table 2 Baseline characteristics of the study population
Characteristics Total population
(N = 633)
Age, median (IQR) 81 (72/87)
Female (%) 396 (62.6)
BMI, median (IQR) 23.4 (20.4/26.4)
Living situation:
- independent (%) 145 (22.9)
- with family help (%) 208 (32.9)
- with home care (%) 214 (33.8)
- nursing home (%) 66 (10.4)
Charlson Comorbidity Index, median (IQR) 2 (1/4)
Number of concomitant drugs, median (IQR) 5 (3/8)
Patients with serious condition, number (%) 387 (61.1)
Patients with DRP, number (%) 77 (12.2)
Patients with DRP as serious condition, number (%) 64 (83.1)
IQR = Inter-Quartile Range.
BMI = Body Mass Index.
MDRD =Modification of Diet in Renal Disease, equation to predict glomerular
filtration rate from serum creatinine [44].
DRP = drug-related problems, as defined in the PCNE-Classification V5.1.
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as P6 (other) (see Figure 2).
Drugs associated with DRP
In our population, each additional drug accounted for
an increase of 10% in the probability of suffering from a
DRP. This association was observed for treatment with 3
to 8 drugs.
In patients presenting with NSC, the use of psy-
chotropic drugs was significantly associated with DRPs
(adjusted OR 2.32, 95% CI 1.39 - 3.88, p = 0.001). This







P1 P2 P3 P4 P5 P6
%
Figure 2 PCNE Classification and percentage of all our
identified drug-related problems (DRP), N = 77. It has six primary
domains for problems: P1 = adverse drug reactions, P2 = Drug
choice problem, P3 = Dosing problem, P4 = Drug use problem,
P5 = Interactions, P6 = other.of the psychotropic drugs used (adjusted OR for one
psychotropic drug.1.89, 95% CI 1.06 - 3.37, p < 0.05
and for 2 psychotropic drugs 2.95, 95% CI 1.51 - 5.76,
p < 0.01). Both the intake of benzodiazepines and anti-
depressants were associated with DRPs (p < 0.001) in
patients with NSC with an adjusted OR of 2.5 (95%
CIs 1.47 - 4.28) and 2.41 (1.46 - 3.98), respectively.
Furthermore the use of anticonvulsants (adjusted OR
3.06, 95% CI 1.55 - 6.02, p < 0.05) and of diuretics (ad-
justed OR 1.8, 95% CI 1.06 - 3.04, p < 0.05) was associ-
ated with an increased risk for DRPs. Further analysis
of the risk associated with diuretics showed that the
use of non-thiazide diuretics did not increase the
risk for DRPs significantly (adjusted OR 1.54, 95%
CI 0.92 - 2.59, p = 0.1), but that the risk for DRPs
was increased with the use of thiazides (adjusted OR 2.09;
95% CI 1.21-3.62, p = 0.009) (see Table 3). In 7 cases, more
than one drug was found to be associated with the respect-
ive DRP. Other drug-classes (e.g. NSAIDs, betablockers,
neuroleptics, opioids) were not significantly associated with
DRPs in our study population with NSC (data not shown).Corresponding final diagnosis
The most frequent underlying causes of DRPs with NSC
were hyponatremia (27%) and drug-overdose (20%). Hy-
ponatremia was most commonly due to thiazides as well
as due to the syndrome of inappropriate secretion of
antidiuretic hormone (SIADH) associated with antide-
pressants or anticonvulsants. Drug-overdose was mostly
due to prescribed benzodiazepines or opiates. A more
detailed list of the corresponding final diagnosis is
shown in Table 3.Discussion
To our knowledge, this is the first study assessing DRPs
in elderly ED patients with non-specific complaints. Our
results show a prevalence of 12.2% for DRPs in this pa-
tient group. Thus, DRPs rank among the top five causes
for non-specific ED presentations, with the vast majority
(83%) causing acute morbidity, classified as a “serious
condition”. This illustrates the importance of early de-
tection of DRPs in the ED. In our study, 60% of DRPs in
patients visiting the ED with NSC were initially not diag-
nosed as medication-related, and were also not consi-
dered in the differential diagnosis.
The risk for a DRP increased with the number of
prescribed medications and with treatment with certain
drug classes, in particular antidepressants, benzodiaze-
pines and anticonvulsants. Intake of thiazides, benzodiaze-
pines, antidepressants and anticonvulsants was associated
with a significantly increased risk for DRPs. The cor-
responding final diagnosis was most commonly hyponatremia
or medication-overdose.
Table 3 Observed DRPs
Involved organ system Involved drugs†
Electrolytes
Hyponatremia Thiazide diuretics (14), Non-thiazide
diuretics (2), Anticonvulsants (2),
Antidepressants± (2), ACE/ARB
blockers (1)
Hypokalemia Non-thiazide diuretics (3), Thiazide
diuretics (1)
Hyperkalemia ACE/ARB blockers (1)
Cardiovascular‡
Bradycardia Beta blockers (1)
Hypotension Beta blockers (1)
Acute heart failure NSAID (1)
Hypovolemia/orthostatic
dysregulation





Non-thiazide diuretics (3), thiazide
diuretics (1)
Acute kidney injury ACE/ARB blockers (1), NSAID (3)
Coagulation system
Intracranial hemorrhage Vitamin-K antagonists (1)
Gastrointestinal
Nausea Opioids (1), Antibiotics (1),
Interferon γ (1)
Gastric ulcer/Gastritis NSAID (2)
Central nervous system
Aggravation of Parkinson’s Underdosing Anti-Parkinson
drugs (1)
Status epilepticus Malcompliance anticonvulsants (2)
Hematology
Neutropenic complication Chemotherapy (1)
Anemia Underdosing of Darbepoetin
alpha (1)
Endocrine
Diabetes mellitus Systemic steroids (1)
Addison systemic steroids (1)
Other
Overdosing Opioids (7), Benzodiazepines (5),
Anticonvulsants (3), Neuroleptics (1)
Falls Neuroleptic (1)
Tumor lysis syndrome Chemotherapy (1)
Abusus Laxatives (1)
†In 7 cases, the DRP was caused by more than one drug class. In 2 cases, one
drug caused more than one DRP.
±SSRI, SNRI, Tricyclic antidepressants.
‡Vital signs within normal range at presentation.
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tation in the ED and have previously been described using
terms, such as “general deterioration”, “loss of energy”,
“weakness” or “home care impossible” [19,20,34,45]. Eld-
erly patients with comorbidities, who are not institutional-
ized, belong to the high-risk population developing DRPs
[4,12,46]. This risk group is highly represented in our
study population. The vast majority of our patients with
NSCs were not institutionalized (89.6%) and had a rela-
tively high burden of comorbidity compared to similar
populations described [47,48].
It has been previously shown that for an elderly ED
population the most common drugs causing DRPs are
diuretics, oral anticoagulants, NSAIDs, antiarrhythmics,
antiplatelet agents and psychotropic drugs [49]. In an-
other study on older patients, Warfarin, Insulin, oral
antiplatelet agents and oral hypoglycemic agents were
implicated alone or in combination in 67% of emergency
hospitalizations for adverse drug events [50]. However,
drug classes such as anticoagulants, NSAIDs, antiar-
rhythmics, and antiplatelet drugs tend to cause specific
symptoms (e.g. bleeding, syncope) or signs (e.g. brady-
cardia, hypotension) in contrast to diuretics. This may
explain the under-representation of DRPs induced by
these substances in our study population whose chief
complaints were merely non-specific.
In accordance with the Beers criteria, we observed sev-
eral cases of DRPs due to SSRIs, benzodiazepines and
anticonvulsants [37]. However we also detected DRPs
associated with drugs which are neither listed in the
Beers criteria of 2003 nor 2012, e.g. thiazide-diuretics
[38]. This discrepancy which was also observed in other
studies [51-53], could be due to a different prescribing
pattern or differing opinions about inappropriateness be-
tween the US and Europe [54,55]. Another publication
compared seven explicit criteria of drug inappropriate-
ness in elderly patients from different countries, includ-
ing the Beers criteria [56]. The only drugs considered
inappropriate by all seven criteria were long-acting ben-
zodiazepines and tricyclic antidepressants [56]. Diuretics
were listed by four of the seven criteria, mainly as po-
tentially inappropriate in combination with other drugs
(e.g. NSAIDs, digoxin) or in patients with a history of
gout [57-60].
Importantly, one study revealed that up to 40% of
drug-related ED visits are not correctly diagnosed by
Emergency Physicians (EP) in a general ED population
[3]. Obviously, DRPs can be difficult to diagnose for
EPs, especially when elderly patients present with non-
specific complaints. In this subgroup of patients, the pro-
portion of initially missed DRPs was even higher in our
study. A potential reason for this might be that EPs are
better at identifying DRPs which relate to the patients’
chief complaints as compared to DRPs with symptoms
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were not specifically addressed in that study. The high
proportion of DRPs that were not identified in our study
strongly supports the hypothesis that non-specific mani-
festations of DRPs are more likely to be missed on admis-
sion than DRPs associated with specific symptoms.
Limitations
Potential limitations of our study include that this study
was conducted at a single urban tertiary care centre in
Switzerland. The lack of an external validation sample
limits the generalizability of the results. Furthermore,
age and gender could not be disguised from the outcome
assessors, leaving the possibility of some degree of in-
corporation bias [31]. Also, the definition of non-specific
disease presentation might not be generalizable to other
settings. Furthermore, we may have missed some cases
of patients with NSC during enrolment (no informed
consent given; non-inclusion during ED crowding). How-
ever, since the data were obtained in a large sample of
consecutive ED patients, our NSC cohort appears stable
when comparing the different parts of the BANC study in
terms of demographic data, rates of acute morbidity, and
mortality rate [22,23].
The results of this study are well in accordance with
previous investigations demonstrating that a relevant
number of drug-related ED visits are undetected [3,46].
Furthermore, the identification of DRPs in patients with
non-specific complaints seems to be even more difficult
than for a general ED population. However, this study
here was not designed to investigate this question, as the
proportion of missed DRPs in specific complaints was
not recorded. An underestimation of DRPs by the expert
panel is possible, especially as the clinical pharmacolo-
gist was not involved in outcome assessment of all 633
cases. However, other studies have demonstrated similar
frequencies of DRPs in ED patients [3,46,61]. Addition-
ally, we did not assess for the individual preventability of
DRPs in this exploratory study.
The risk of falls is known to be significantly associated
with psychotropic medication, especially for benzodiaze-
pines and other hypnotics, as well as for antiepileptics
[62]. However, trauma patients with injurious falls were
not included in our study.
Conclusion
The ED is an environment where medication regimens of
elderly patients need to be screened systematically for
drug-related problems due to both the frequency and the
possible severity of the condition. Patients with non-
specific complaints are known to be at high risk for
complications – our findings add DRPs to the long list of
possible complications and missed conditions in this
population. It is important to realize that the number ofmedications and treatment with specific drugs or drug
classes such as thiazides, benzodiazepines, antidepres-
sants, and anticonvulsants are significantly associated with
DRPs, resulting in ED visits with non-specific complaints.
Better knowledge of these relationships may help to de-
crease the frequency of missed DRPs in this patient group.
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